搜尋結果
AstraZeneca to build $1.5-bln cancer drug plant in Singapore
Reuters· 4 日前, opens new tab plans to build a $1.5 billion manufacturing facility in Singapore to produce a ...
Opinion | Swift drug approvals the right medicine for Hong Kong
South China Morning Post· 3 日前Pharmaceutical firms may submit applications to the Hospital Authority directly without going through doctors under the ...
Ways to sharpen EV sector's competitive edge
China Daily· 2 日前China's new energy vehicles (EVs) have emerged as global leaders, driven by the country's robust research and development ...
HKU Business School investigates allegations of fake qualifications in postgraduate enrolments
Dimsum Daily· 4 日前21st May 2024 – (Hong Kong) HKU Business School is currently conducting a thorough investigation following allegations that ...
Can Rising Cloud And AI Capabilities Lift OTEX Out Of Its Slump?
Forbes· 4 日前Julius Juenemann, CFA is the equity analyst and associate editor of the Forbes Special Situation Survey and Forbes Investor ...